Katrine DiBona, Novo Nordisk: “We aim to serve four million African patients by 2026”
The Danish group’s corporate vice president, global public affairs and sustainability, described the impact of the recent agreement with Aspen to produce insulin in Africa, the continuing difficulties of distribution, and Novo Nordisk’s pricing strategy.
28/11/2023 at 19h15, by Africa Business+
Recommended articles
Health
17/05/2022 at 14h37, by Africa Business+
Exeo Capital expects Chemical Process Technologies to generate $10m in revenues by 2022
The South African investment fund targets animal pharmaceuticals in southern Africa and Latin America.
Health
25/04/2022 at 12h00, by Africa Business+
BluePeak invests in Africure Pharmaceutical and targets two other companies
The young alternative asset management firm based in London, Nairobi and Tunis is to provide mezzanine...
Health
26/09/2019 at 16h47, by Africa Business+
South Africa: with Aspen, India’s Laurus Labs gains access to the public antiretroviral sector
Generic pharmaceutical firm Laurus Labs is to acquire 100% of the shares of a subsidiary of South African...